A multi-center, double-blind, randomized, placebo-controlled, parallel design study to evaluate the efficacy and safety of intravenous tedisamil sesquifumarate in the rapid conversion to normal sinus rhythm in female subjects with recent onset atrial fibrillation or flutter.
Latest Information Update: 09 Sep 2024
At a glance
- Drugs Tedisamil (Primary)
- Indications Atrial fibrillation; Atrial flutter
- Focus Pharmacokinetics; Registrational; Therapeutic Use
- 20 Apr 2010 Additional trial locations (USA, Italy and Germany) added as reported by ClinicalTrials.gov record.
- 06 Nov 2005 New trial record.